Global Oncology-based In-vivo CRO Market Growth (Status and Outlook) 2025-2031

Product Code: 1705217

Industry: Medical Care

Published: Jul 13,2025

Pages: 110

Delivery Time: 2-3 business days

Global Oncology-based In-vivo CRO Market Growth (Status and Outlook) 2025-2031

Product Code: 1705217

Industry: Medical Care

Published: Jul 13,2025

Pages: 110

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Oncology-based In-vivo CRO market size will reach US$ 2685 million by 2031.

Oncology-based In-vivo CRO refers to specialized contract research organizations that provide preclinical in-vivo services focused on cancer drug development. These CROs conduct animal model studies to evaluate the efficacy, toxicity, pharmacokinetics, and mechanisms of anticancer drugs. They utilize xenograft models (e.g., cell line-derived xenografts, patient-derived xenografts), genetically engineered mouse models, orthotopic tumor models, and metastasis models to simulate human cancer biology. Such services are essential for pharmaceutical companies and biotech firms seeking to accelerate oncology R&D pipelines while minimizing infrastructure investment and regulatory risk.

United States market for Oncology-based In-vivo CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oncology-based In-vivo CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oncology-based In-vivo CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oncology-based In-vivo CRO players cover Charles River Laboratories, ICON, WuXi AppTec, Crown Bioscience, Labcorp Drug Development, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oncology-based In-vivo CRO Industry Forecast” looks at past sales and reviews total world Oncology-based In-vivo CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology-based In-vivo CRO sales for 2025 through 2031. With Oncology-based In-vivo CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology-based In-vivo CRO industry.

This Insight Report provides a comprehensive analysis of the global Oncology-based In-vivo CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology-based In-vivo CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology-based In-vivo CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology-based In-vivo CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology-based In-vivo CRO.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology-based In-vivo CRO market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Efficacy Evaluation
    Combination Therapy Testing
    Tumor Immune Microenvironment Assessment
    Others

Segmentation by Application:
    Pharmaceutical Companies
    Academic and Research Institutions
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Charles River Laboratories
    ICON
    WuXi AppTec
    Crown Bioscience
    Labcorp Drug Development
    Eurofins Scientific
    Taconic Biosciences
    The Jackson Laboratory
    Evotec
    Champions Oncology
    Thermo Fisher Scientific
    IMV
    Pharmaron
    Living Tumor Laboratory

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Oncology-based In-vivo CRO Market Size (2020-2031)
        2.1.2 Oncology-based In-vivo CRO Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Oncology-based In-vivo CRO by Country/Region (2020, 2024 & 2031)
    2.2 Oncology-based In-vivo CRO Segment by Type
        2.2.1 Efficacy Evaluation
        2.2.2 Combination Therapy Testing
        2.2.3 Tumor Immune Microenvironment Assessment
        2.2.4 Others
    2.3 Oncology-based In-vivo CRO Market Size by Type
        2.3.1 Oncology-based In-vivo CRO Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
    2.4 Oncology-based In-vivo CRO Segment by Application
        2.4.1 Pharmaceutical Companies
        2.4.2 Academic and Research Institutions
        2.4.3 Others
    2.5 Oncology-based In-vivo CRO Market Size by Application
        2.5.1 Oncology-based In-vivo CRO Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)

3 Oncology-based In-vivo CRO Market Size by Player
    3.1 Oncology-based In-vivo CRO Market Size Market Share by Player
        3.1.1 Global Oncology-based In-vivo CRO Revenue by Player (2020-2025)
        3.1.2 Global Oncology-based In-vivo CRO Revenue Market Share by Player (2020-2025)
    3.2 Global Oncology-based In-vivo CRO Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Oncology-based In-vivo CRO by Region
    4.1 Oncology-based In-vivo CRO Market Size by Region (2020-2025)
    4.2 Global Oncology-based In-vivo CRO Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Oncology-based In-vivo CRO Market Size Growth (2020-2025)
    4.4 APAC Oncology-based In-vivo CRO Market Size Growth (2020-2025)
    4.5 Europe Oncology-based In-vivo CRO Market Size Growth (2020-2025)
    4.6 Middle East & Africa Oncology-based In-vivo CRO Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Oncology-based In-vivo CRO Market Size by Country (2020-2025)
    5.2 Americas Oncology-based In-vivo CRO Market Size by Type (2020-2025)
    5.3 Americas Oncology-based In-vivo CRO Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Oncology-based In-vivo CRO Market Size by Region (2020-2025)
    6.2 APAC Oncology-based In-vivo CRO Market Size by Type (2020-2025)
    6.3 APAC Oncology-based In-vivo CRO Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Oncology-based In-vivo CRO Market Size by Country (2020-2025)
    7.2 Europe Oncology-based In-vivo CRO Market Size by Type (2020-2025)
    7.3 Europe Oncology-based In-vivo CRO Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Oncology-based In-vivo CRO by Region (2020-2025)
    8.2 Middle East & Africa Oncology-based In-vivo CRO Market Size by Type (2020-2025)
    8.3 Middle East & Africa Oncology-based In-vivo CRO Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Oncology-based In-vivo CRO Market Forecast
    10.1 Global Oncology-based In-vivo CRO Forecast by Region (2026-2031)
        10.1.1 Global Oncology-based In-vivo CRO Forecast by Region (2026-2031)
        10.1.2 Americas Oncology-based In-vivo CRO Forecast
        10.1.3 APAC Oncology-based In-vivo CRO Forecast
        10.1.4 Europe Oncology-based In-vivo CRO Forecast
        10.1.5 Middle East & Africa Oncology-based In-vivo CRO Forecast
    10.2 Americas Oncology-based In-vivo CRO Forecast by Country (2026-2031)
        10.2.1 United States Market Oncology-based In-vivo CRO Forecast
        10.2.2 Canada Market Oncology-based In-vivo CRO Forecast
        10.2.3 Mexico Market Oncology-based In-vivo CRO Forecast
        10.2.4 Brazil Market Oncology-based In-vivo CRO Forecast
    10.3 APAC Oncology-based In-vivo CRO Forecast by Region (2026-2031)
        10.3.1 China Oncology-based In-vivo CRO Market Forecast
        10.3.2 Japan Market Oncology-based In-vivo CRO Forecast
        10.3.3 Korea Market Oncology-based In-vivo CRO Forecast
        10.3.4 Southeast Asia Market Oncology-based In-vivo CRO Forecast
        10.3.5 India Market Oncology-based In-vivo CRO Forecast
        10.3.6 Australia Market Oncology-based In-vivo CRO Forecast
    10.4 Europe Oncology-based In-vivo CRO Forecast by Country (2026-2031)
        10.4.1 Germany Market Oncology-based In-vivo CRO Forecast
        10.4.2 France Market Oncology-based In-vivo CRO Forecast
        10.4.3 UK Market Oncology-based In-vivo CRO Forecast
        10.4.4 Italy Market Oncology-based In-vivo CRO Forecast
        10.4.5 Russia Market Oncology-based In-vivo CRO Forecast
    10.5 Middle East & Africa Oncology-based In-vivo CRO Forecast by Region (2026-2031)
        10.5.1 Egypt Market Oncology-based In-vivo CRO Forecast
        10.5.2 South Africa Market Oncology-based In-vivo CRO Forecast
        10.5.3 Israel Market Oncology-based In-vivo CRO Forecast
        10.5.4 Turkey Market Oncology-based In-vivo CRO Forecast
    10.6 Global Oncology-based In-vivo CRO Forecast by Type (2026-2031)
    10.7 Global Oncology-based In-vivo CRO Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Oncology-based In-vivo CRO Forecast

11 Key Players Analysis
    11.1 Charles River Laboratories
        11.1.1 Charles River Laboratories Company Information
        11.1.2 Charles River Laboratories Oncology-based In-vivo CRO Product Offered
        11.1.3 Charles River Laboratories Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Charles River Laboratories Main Business Overview
        11.1.5 Charles River Laboratories Latest Developments
    11.2 ICON
        11.2.1 ICON Company Information
        11.2.2 ICON Oncology-based In-vivo CRO Product Offered
        11.2.3 ICON Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 ICON Main Business Overview
        11.2.5 ICON Latest Developments
    11.3 WuXi AppTec
        11.3.1 WuXi AppTec Company Information
        11.3.2 WuXi AppTec Oncology-based In-vivo CRO Product Offered
        11.3.3 WuXi AppTec Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 WuXi AppTec Main Business Overview
        11.3.5 WuXi AppTec Latest Developments
    11.4 Crown Bioscience
        11.4.1 Crown Bioscience Company Information
        11.4.2 Crown Bioscience Oncology-based In-vivo CRO Product Offered
        11.4.3 Crown Bioscience Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Crown Bioscience Main Business Overview
        11.4.5 Crown Bioscience Latest Developments
    11.5 Labcorp Drug Development
        11.5.1 Labcorp Drug Development Company Information
        11.5.2 Labcorp Drug Development Oncology-based In-vivo CRO Product Offered
        11.5.3 Labcorp Drug Development Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Labcorp Drug Development Main Business Overview
        11.5.5 Labcorp Drug Development Latest Developments
    11.6 Eurofins Scientific
        11.6.1 Eurofins Scientific Company Information
        11.6.2 Eurofins Scientific Oncology-based In-vivo CRO Product Offered
        11.6.3 Eurofins Scientific Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Eurofins Scientific Main Business Overview
        11.6.5 Eurofins Scientific Latest Developments
    11.7 Taconic Biosciences
        11.7.1 Taconic Biosciences Company Information
        11.7.2 Taconic Biosciences Oncology-based In-vivo CRO Product Offered
        11.7.3 Taconic Biosciences Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 Taconic Biosciences Main Business Overview
        11.7.5 Taconic Biosciences Latest Developments
    11.8 The Jackson Laboratory
        11.8.1 The Jackson Laboratory Company Information
        11.8.2 The Jackson Laboratory Oncology-based In-vivo CRO Product Offered
        11.8.3 The Jackson Laboratory Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 The Jackson Laboratory Main Business Overview
        11.8.5 The Jackson Laboratory Latest Developments
    11.9 Evotec
        11.9.1 Evotec Company Information
        11.9.2 Evotec Oncology-based In-vivo CRO Product Offered
        11.9.3 Evotec Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Evotec Main Business Overview
        11.9.5 Evotec Latest Developments
    11.10 Champions Oncology
        11.10.1 Champions Oncology Company Information
        11.10.2 Champions Oncology Oncology-based In-vivo CRO Product Offered
        11.10.3 Champions Oncology Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Champions Oncology Main Business Overview
        11.10.5 Champions Oncology Latest Developments
    11.11 Thermo Fisher Scientific
        11.11.1 Thermo Fisher Scientific Company Information
        11.11.2 Thermo Fisher Scientific Oncology-based In-vivo CRO Product Offered
        11.11.3 Thermo Fisher Scientific Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Thermo Fisher Scientific Main Business Overview
        11.11.5 Thermo Fisher Scientific Latest Developments
    11.12 IMV
        11.12.1 IMV Company Information
        11.12.2 IMV Oncology-based In-vivo CRO Product Offered
        11.12.3 IMV Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 IMV Main Business Overview
        11.12.5 IMV Latest Developments
    11.13 Pharmaron
        11.13.1 Pharmaron Company Information
        11.13.2 Pharmaron Oncology-based In-vivo CRO Product Offered
        11.13.3 Pharmaron Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Pharmaron Main Business Overview
        11.13.5 Pharmaron Latest Developments
    11.14 Living Tumor Laboratory
        11.14.1 Living Tumor Laboratory Company Information
        11.14.2 Living Tumor Laboratory Oncology-based In-vivo CRO Product Offered
        11.14.3 Living Tumor Laboratory Oncology-based In-vivo CRO Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Living Tumor Laboratory Main Business Overview
        11.14.5 Living Tumor Laboratory Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Oncology-based In-vivo CRO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Oncology-based In-vivo CRO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Efficacy Evaluation
 Table 4. Major Players of Combination Therapy Testing
 Table 5. Major Players of Tumor Immune Microenvironment Assessment
 Table 6. Major Players of Others
 Table 7. Oncology-based In-vivo CRO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 8. Global Oncology-based In-vivo CRO Market Size by Type (2020-2025) & ($ millions)
 Table 9. Global Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
 Table 10. Oncology-based In-vivo CRO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 11. Global Oncology-based In-vivo CRO Market Size by Application (2020-2025) & ($ millions)
 Table 12. Global Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)
 Table 13. Global Oncology-based In-vivo CRO Revenue by Player (2020-2025) & ($ millions)
 Table 14. Global Oncology-based In-vivo CRO Revenue Market Share by Player (2020-2025)
 Table 15. Oncology-based In-vivo CRO Key Players Head office and Products Offered
 Table 16. Oncology-based In-vivo CRO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 17. New Products and Potential Entrants
 Table 18. Mergers & Acquisitions, Expansion
 Table 19. Global Oncology-based In-vivo CRO Market Size by Region (2020-2025) & ($ millions)
 Table 20. Global Oncology-based In-vivo CRO Market Size Market Share by Region (2020-2025)
 Table 21. Global Oncology-based In-vivo CRO Revenue by Country/Region (2020-2025) & ($ millions)
 Table 22. Global Oncology-based In-vivo CRO Revenue Market Share by Country/Region (2020-2025)
 Table 23. Americas Oncology-based In-vivo CRO Market Size by Country (2020-2025) & ($ millions)
 Table 24. Americas Oncology-based In-vivo CRO Market Size Market Share by Country (2020-2025)
 Table 25. Americas Oncology-based In-vivo CRO Market Size by Type (2020-2025) & ($ millions)
 Table 26. Americas Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
 Table 27. Americas Oncology-based In-vivo CRO Market Size by Application (2020-2025) & ($ millions)
 Table 28. Americas Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)
 Table 29. APAC Oncology-based In-vivo CRO Market Size by Region (2020-2025) & ($ millions)
 Table 30. APAC Oncology-based In-vivo CRO Market Size Market Share by Region (2020-2025)
 Table 31. APAC Oncology-based In-vivo CRO Market Size by Type (2020-2025) & ($ millions)
 Table 32. APAC Oncology-based In-vivo CRO Market Size by Application (2020-2025) & ($ millions)
 Table 33. Europe Oncology-based In-vivo CRO Market Size by Country (2020-2025) & ($ millions)
 Table 34. Europe Oncology-based In-vivo CRO Market Size Market Share by Country (2020-2025)
 Table 35. Europe Oncology-based In-vivo CRO Market Size by Type (2020-2025) & ($ millions)
 Table 36. Europe Oncology-based In-vivo CRO Market Size by Application (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Oncology-based In-vivo CRO Market Size by Region (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Oncology-based In-vivo CRO Market Size by Type (2020-2025) & ($ millions)
 Table 39. Middle East & Africa Oncology-based In-vivo CRO Market Size by Application (2020-2025) & ($ millions)
 Table 40. Key Market Drivers & Growth Opportunities of Oncology-based In-vivo CRO
 Table 41. Key Market Challenges & Risks of Oncology-based In-vivo CRO
 Table 42. Key Industry Trends of Oncology-based In-vivo CRO
 Table 43. Global Oncology-based In-vivo CRO Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 44. Global Oncology-based In-vivo CRO Market Size Market Share Forecast by Region (2026-2031)
 Table 45. Global Oncology-based In-vivo CRO Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 46. Global Oncology-based In-vivo CRO Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 47. Charles River Laboratories Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 48. Charles River Laboratories Oncology-based In-vivo CRO Product Offered
 Table 49. Charles River Laboratories Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 50. Charles River Laboratories Main Business
 Table 51. Charles River Laboratories Latest Developments
 Table 52. ICON Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 53. ICON Oncology-based In-vivo CRO Product Offered
 Table 54. ICON Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 55. ICON Main Business
 Table 56. ICON Latest Developments
 Table 57. WuXi AppTec Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 58. WuXi AppTec Oncology-based In-vivo CRO Product Offered
 Table 59. WuXi AppTec Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 60. WuXi AppTec Main Business
 Table 61. WuXi AppTec Latest Developments
 Table 62. Crown Bioscience Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 63. Crown Bioscience Oncology-based In-vivo CRO Product Offered
 Table 64. Crown Bioscience Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 65. Crown Bioscience Main Business
 Table 66. Crown Bioscience Latest Developments
 Table 67. Labcorp Drug Development Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 68. Labcorp Drug Development Oncology-based In-vivo CRO Product Offered
 Table 69. Labcorp Drug Development Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 70. Labcorp Drug Development Main Business
 Table 71. Labcorp Drug Development Latest Developments
 Table 72. Eurofins Scientific Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 73. Eurofins Scientific Oncology-based In-vivo CRO Product Offered
 Table 74. Eurofins Scientific Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 75. Eurofins Scientific Main Business
 Table 76. Eurofins Scientific Latest Developments
 Table 77. Taconic Biosciences Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 78. Taconic Biosciences Oncology-based In-vivo CRO Product Offered
 Table 79. Taconic Biosciences Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 80. Taconic Biosciences Main Business
 Table 81. Taconic Biosciences Latest Developments
 Table 82. The Jackson Laboratory Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 83. The Jackson Laboratory Oncology-based In-vivo CRO Product Offered
 Table 84. The Jackson Laboratory Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 85. The Jackson Laboratory Main Business
 Table 86. The Jackson Laboratory Latest Developments
 Table 87. Evotec Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 88. Evotec Oncology-based In-vivo CRO Product Offered
 Table 89. Evotec Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 90. Evotec Main Business
 Table 91. Evotec Latest Developments
 Table 92. Champions Oncology Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 93. Champions Oncology Oncology-based In-vivo CRO Product Offered
 Table 94. Champions Oncology Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 95. Champions Oncology Main Business
 Table 96. Champions Oncology Latest Developments
 Table 97. Thermo Fisher Scientific Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 98. Thermo Fisher Scientific Oncology-based In-vivo CRO Product Offered
 Table 99. Thermo Fisher Scientific Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 100. Thermo Fisher Scientific Main Business
 Table 101. Thermo Fisher Scientific Latest Developments
 Table 102. IMV Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 103. IMV Oncology-based In-vivo CRO Product Offered
 Table 104. IMV Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 105. IMV Main Business
 Table 106. IMV Latest Developments
 Table 107. Pharmaron Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 108. Pharmaron Oncology-based In-vivo CRO Product Offered
 Table 109. Pharmaron Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 110. Pharmaron Main Business
 Table 111. Pharmaron Latest Developments
 Table 112. Living Tumor Laboratory Details, Company Type, Oncology-based In-vivo CRO Area Served and Its Competitors
 Table 113. Living Tumor Laboratory Oncology-based In-vivo CRO Product Offered
 Table 114. Living Tumor Laboratory Oncology-based In-vivo CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 115. Living Tumor Laboratory Main Business
 Table 116. Living Tumor Laboratory Latest Developments


List of Figures
 Figure 1. Oncology-based In-vivo CRO Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Oncology-based In-vivo CRO Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Oncology-based In-vivo CRO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Oncology-based In-vivo CRO Sales Market Share by Country/Region (2024)
 Figure 8. Oncology-based In-vivo CRO Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Oncology-based In-vivo CRO Market Size Market Share by Type in 2024
 Figure 10. Oncology-based In-vivo CRO in Pharmaceutical Companies
 Figure 11. Global Oncology-based In-vivo CRO Market: Pharmaceutical Companies (2020-2025) & ($ millions)
 Figure 12. Oncology-based In-vivo CRO in Academic and Research Institutions
 Figure 13. Global Oncology-based In-vivo CRO Market: Academic and Research Institutions (2020-2025) & ($ millions)
 Figure 14. Oncology-based In-vivo CRO in Others
 Figure 15. Global Oncology-based In-vivo CRO Market: Others (2020-2025) & ($ millions)
 Figure 16. Global Oncology-based In-vivo CRO Market Size Market Share by Application in 2024
 Figure 17. Global Oncology-based In-vivo CRO Revenue Market Share by Player in 2024
 Figure 18. Global Oncology-based In-vivo CRO Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Oncology-based In-vivo CRO Market Size 2020-2025 ($ millions)
 Figure 20. APAC Oncology-based In-vivo CRO Market Size 2020-2025 ($ millions)
 Figure 21. Europe Oncology-based In-vivo CRO Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Oncology-based In-vivo CRO Market Size 2020-2025 ($ millions)
 Figure 23. Americas Oncology-based In-vivo CRO Value Market Share by Country in 2024
 Figure 24. United States Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Oncology-based In-vivo CRO Market Size Market Share by Region in 2024
 Figure 29. APAC Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)
 Figure 31. China Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Oncology-based In-vivo CRO Market Size Market Share by Country in 2024
 Figure 38. Europe Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Oncology-based In-vivo CRO Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Oncology-based In-vivo CRO Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Oncology-based In-vivo CRO Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Oncology-based In-vivo CRO Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 54. APAC Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 55. Europe Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 57. United States Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 58. Canada Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 61. China Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 62. Japan Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 63. Korea Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 65. India Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 66. Australia Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 67. Germany Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 68. France Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 69. UK Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 70. Italy Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 71. Russia Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 74. Israel Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)
 Figure 76. Global Oncology-based In-vivo CRO Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Oncology-based In-vivo CRO Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Oncology-based In-vivo CRO Market Size 2026-2031 ($ millions)

Companies Mentioned

Charles River Laboratories

ICON

WuXi AppTec

Crown Bioscience

Labcorp Drug Development

Eurofins Scientific

Taconic Biosciences

The Jackson Laboratory

Evotec

Champions Oncology

Thermo Fisher Scientific

IMV

Pharmaron

Living Tumor Laboratory

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff